Walleye Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.03M Sell
112,000
-10,100
-8% -$808K 0.03% 586
2025
Q4
$11.6M Buy
122,100
+81,100
+198% +$7.95M 0.04% 554
2025
Q3
$4M Sell
41,000
-10,400
-20% -$1.08M 0.02% 1070
2025
Q2
$5.52M Sell
51,400
-44,900
-47% -$4.54M 0.02% 819
2025
Q1
$9.71M Buy
96,300
+40,800
+74% +$4.11M 0.04% 456
2024
Q4
$4.96M Buy
55,500
+5,400
+11% +$475K 0.01% 1081
2024
Q3
$4.2M Sell
50,100
-11,900
-19% -$938K 0.01% 1311
2024
Q2
$4.77M Sell
62,000
-25,500
-29% -$1.87M 0.01% 1324
2024
Q1
$5.99M Sell
87,500
-46,800
-35% -$3.01M 0.01% 1169
2023
Q4
$7.76M Sell
134,300
-126,900
-49% -$6.77M 0.02% 822
2023
Q3
$13.8M Buy
261,200
+126,400
+94% +$6.63M 0.04% 410
2023
Q2
$7.29M Buy
134,800
+126,400
+1,505% +$6.6M 0.03% 544
2023
Q1
$420K Buy
8,400
+1,900
+29% +$89.5K 0.01% 1852
2022
Q4
$301K Sell
6,500
-5,600
-46% -$242K 0.01% 1783
2022
Q3
$469K Buy
+12,100
New +$485K 0.01% 1526
2019
Q4
Sell
-7,500
Closed -$305K 1812
2019
Q3
$305K Buy
+7,500
New +$318K 0.02% 969
2019
Q2
Sell
-7,100
Closed -$272K 1743
2019
Q1
$272K Buy
+7,100
New +$271K 0.04% 639

Other funds holding BSX

Walleye Capital's BSX Position: Q1 2026 in Review

Walleye Capital reduced its Boston Scientific (BSX) stake by 59% in Q1 2026, selling an estimated $96.4M and leaving 835,952 shares worth $52.5M. The position accounts for 0.22% of the portfolio, ranked #41.

Walleye Capital first reported a position in BSX in Q2 2020 and has held it in 22 quarters since. The position peaked at $195M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Walleye Capital held 835,952 shares of Boston Scientific worth $52.5M as of Q1 2026.
  • Walleye Capital sold 1,205,462 Boston Scientific shares in Q1 2026, an estimated $96.4M.
  • Boston Scientific made up 0.22% of Walleye Capital's portfolio in Q1 2026, its #41 holding.
  • Walleye Capital first reported a position in Boston Scientific in Q2 2020 and has held it in 22 quarters since.
  • Walleye Capital's Boston Scientific position peaked at $195M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.